Skip to main content
HCPCS J0888 · Level II · Part B drug

J0888: epoetin beta (Mircera), non-ESRD, HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J0888

Billing unit
1 MCG
Epoetin beta non esrd
ASP payment limit
$1.196
October 2026; +9.7% vs July 2026
Practitioner MUE
360
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
3
13 states

TL;DR

HCPCS J0888 is the Level II code for Injection, epoetin beta, 1 microgram, (for non esrd use), billed per 1 MCG. The Medicare Part B ASP payment limit for October 2026 is $1.196 per billing unit, up 9.7% from July 2026. The practitioner MUE allows up to 360 units per date of service (MAI 3), so a full 360-unit day is $430.56 at the current limit. Under OPPS it carries status indicator N. The descriptor restricts this code to non-ESRD use; the ESRD-on-dialysis counterpart is a separate code and billing the wrong one is a frequent reason for CARC 16 returns. Other HCPCS codes whose descriptor names epoetin beta: J0887 (for ESRD patients on dialysis). The ASP crosswalk maps 7 NDCs to it, sold as Mircera by Vifor (International) Inc. 3 Medicare coverage articles list the code across 13 states, including A56795.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J0888 at $1.196 per 1 MCG for October 2026, derived from manufacturer average sales price plus 6%, compared with $1.09 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J0888
QuarterPayment limitPerCoinsurance
October 2026$1.1961 MCG20%
July 2026$1.091 MCG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 7 NDCs from 1 labeler to J0888. Report the NDC in the claim's drug segment and bill the number of J0888 units that equals the quantity administered divided by 1 MCG; the last column gives units per full package.

NDCs that crosswalk to J0888
NDCDrug nameLabelerPackage sizeBilling units / package
59353-0400-09MirceraVifor (International) Inc.0.3 × 130
59353-0401-09MirceraVifor (International) Inc.0.3 × 150
59353-0402-09MirceraVifor (International) Inc.0.3 × 175
59353-0403-09MirceraVifor (International) Inc.0.3 × 1100
59353-0404-09MirceraVifor (International) Inc.0.3 × 1150
59353-0405-09MirceraVifor (International) Inc.0.3 × 1200
59353-0407-09MirceraVifor (International) Inc.0.3 × 1120

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J0888. For practitioners the limit is 360 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J0888 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services3603 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital3603 Date of Service Edit: ClinicalPrescribing Information
DME supplier03 Date of Service Edit: ClinicalCMS Policy

MUE for J0888 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J0888 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J0888 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J0888 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

3 current Medicare Administrative Contractor articles list J0888 in their HCPCS tables, covering 13 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J0888
ArticleTitleContractor(s)StatesRelated LCD
A56795Billing and Coding: Erythropoiesis Stimulating Agents (ESAs)Wisconsin Physicians Service Insurance CorporationIA KS MO NEL34633, L38446
A58982Billing and Coding: Erythropoiesis Stimulating AgentsPalmetto GBANC SC VA WVL39237
A60381Billing and Coding: Erythropoiesis Stimulating AgentsWellpoint FederalCT IL MN NY WIL40334

Diagnoses Medicare contractors cover for J0888

3 billing and coding articles attach a covered diagnosis list to J0888: 12 distinct ICD-10-CM codes in all. The 12 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 12 covered ICD-10-CM codes for J0888
ICD-10-CMDescription (FY2027)Articles covering
D63.1Anemia in chronic kidney disease3 of 3
I12.0Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease3 of 3
I13.11Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease3 of 3
I13.2Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease3 of 3
N18.32Chronic kidney disease, stage 3b3 of 3
N18.4Chronic kidney disease, stage 4 (severe)3 of 3
N18.5Chronic kidney disease, stage 53 of 3
I12.9Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease2 of 3
I13.0Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease2 of 3
I13.10Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease2 of 3
N18.31Chronic kidney disease, stage 3a2 of 3
N18.30Chronic kidney disease, stage 3 unspecified1 of 3

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J0888 are counted here: a group whose instructions name J0888, together with any unnamed groups directly after it, read as continuations of those instructions. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to J0888, by article
ArticleContractorGroups that applyCovered codes for J0888Full list
A56795Wisconsin Physicians Service Insurance Corporationgroups 2 and 3 apply to J088812On LCD L34633
A58982Palmetto GBAgroup 2 applies to J08887On LCD L39237
A60381Wellpoint Federalgroup 2 applies to J088811On LCD L40334

Local coverage policies that list J0888

3 active Local Coverage Determinations list J0888 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J0888 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J0888 carries payment indicator N1, which CMS defines as "Packaged service/item; no separate payment made". An N1 drug is packaged in the ASC: the facility receives no separate payment because the surgical procedure's rate already includes it.

Common denials for J0888 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J0888

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J0888

What does HCPCS code J0888 describe?

J0888 is defined by CMS as "Injection, epoetin beta, 1 microgram, (for non esrd use)". Each billing unit represents 1 MCG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J0888 a CPT code?

No. J0888 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as epoetin beta (Mircera); CPT codes are five-character codes maintained by the AMA. On a Part B claim J0888 reports the drug itself in 1 mcg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J0888 in October 2026?

The ASP-based payment limit is $1.196 per 1 MCG, with 20% beneficiary coinsurance. The July 2026 limit was $1.09. Commercial payers use their own fee schedules.

How many units of J0888 can be billed per day?

The practitioner Medically Unlikely Edit is 360 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J0888?

The October 2026 ASP crosswalk lists 7 NDCs from 1 labeler: Mircera (Vifor (International) Inc.). For example NDC 59353-0400-09 (package size 0.3) equals 30 billing units of J0888.

Does J0888 have NCCI bundling edits?

No active practitioner PTP pairs list J0888 as a column-1 or column-2 code in the v323r0 release.

J0888 vs J0887: what is the difference?

Both are HCPCS Level II codes whose descriptor names epoetin beta. What sets J0887 apart: for ESRD patients on dialysis. J0888 is billed per 1 mcg, limit $1.196, MUE 360; J0887 is billed per 1 mcg, limit $1.196, MUE 360. Report the code whose descriptor matches the product and setting in the record.

Which Medicare coverage articles mention J0888?

3 current Billing and Coding Articles in the Medicare Coverage Database list J0888, covering 13 states: A56795 (Billing and Coding: Erythropoiesis Stimulating Agents (ESAs)); A58982 (Billing and Coding: Erythropoiesis Stimulating Agents); A60381 (Billing and Coding: Erythropoiesis Stimulating Agents).

What diagnosis codes support J0888?

3 Medicare billing and coding articles list 12 covered ICD-10-CM codes for J0888 between them, for example D63.1 (Anemia in chronic kidney disease); I12.0 (Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease); I13.11 (Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease); I13.2 (Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease); N18.32 (Chronic kidney disease, stage 3b). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.